Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4029457 | Ophthalmology | 2007 | 10 Pages |
Abstract
In cases of DME with good visual acuity, peribulbar triamcinolone, with or without focal photocoagulation, is unlikely to be of substantial benefit. Based on these results, a phase III trial to evaluate the benefit of these treatments for mild DME is not warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Diabetic Retinopathy Clinical Research Network Diabetic Retinopathy Clinical Research Network,